Exhibit 99.1
 (GLOBAL MED LOGO)
    
    (LOGO)
 GLOBAL MED TECHNOLOGIES ® ANNOUNCES THIRD
QUARTER AND FIRST NINE MONTHS RESULTS
 First Nine Months Revenues are Record High, $23.68 Million
Record Q3 Net Income of $1.10 million* and Revenues of $7.26 million
 DENVER, CO November 11, 2009 ®




---



##### 



**
    
    Includes recurring revenues from the Hemo-Net acquisition that was completed on November 3, 2009.
 Third Quarter 2009 Business Developments and Announcements:
 
    
    The Companys Inlog subsidiary licensed its EdgeCell cellular therapy software and
EdgeLab/HLA laboratory information management software for human leukocyte antigen matching
(marketed as Labo Serveur in France) to Héma-Québec, the official blood supplier for
Quebec, Canada.
    
    A binding letter of intent to market verIDhemos, a breakthrough transfusion safety RFID
product, was signed with verIDentia SL of Spain.
    
    Global Meds Wyndgate division, together with one of its major channel partners,
licensed its ElDorado Donor, Donor Doc and eDonor solutions to a major East Coast pediatric
hospital.
  ® ®
 1-866-394-9731 1-706-643-7541 Global Med Third Quarter Financial Results 40197655
  2




---



##### 



GLOBAL MED TECHNOLOGIES, INC. (OTC Bulletin Board: GLOB.OB)
 Selected Operating Results (Unaudited)
Three Months Ended September 30,
In (000s) Except Per Share Information
 2009*
    
    2008Revenues
    
    $
    7,257
    
    
    $
    6,940Cost of revenues
    
    
    2,812
    
    
    
    2,759Operating expenses, exclusive of legal accrual reversal
    
    
    4,325
    
    
    
    4,299Legal accrual reversal
    
    
    (1,004
    )
    
    
    Income from operations
    
    $
    1,124
    
    
    
    (118
    )Other income (expense), net
    
    
    (164
    )
    
    
    (164
    )Income tax benefit
    
    
    143
    
    
    
    54Net income (loss)
    
    $
    1,103
    
    
    $
    (228
    )Income per share:Basic
    
    $
    0.03
    
    
    $
    (0.01
    )Diluted
    
    $
    0.02
    
    
    $
    (0.01
    )EBITDA
    
    $
    1,496
    
    
    $
    230Weighted-average shares outstanding:Basic
    
    
    35,891
    
    
    
    30,754Diluted
    
    
    45,532
    
    
    
    30,754
 3




---



##### 



Selected Operating Results (Unaudited)
Nine Months Ended September 30,
In (000s) Except Per Share Information
 2009*
    
    2008Revenues
    
    $
    23,675
    
    
    $
    16,378Cost of revenues
    
    
    9,018
    
    
    
    6,177Operating expenses, exclusive of legal accrual reversal
    
    
    12,859
    
    
    
    9,361Legal accrual reversal
    
    
    (1,004
    )
    
    
    Income from operations
    
    
    2,802
    
    
    
    840Other income (expense), net
    
    
    (542
    )
    
    
    (126
    )Income taxes
    
    
    (563
    )
    
    
    (430
    )Net income
    
    $
    1,697
    
    
    $
    284EBITDA
    
    
    3,845
    
    
    
    1,302Income per share:Basic
    
    $
    0.05
    
    
    $
    0.01Diluted
    
    $
    0.04
    
    
    $
    0.01Weighted-average shares outstanding:Basic
    
    
    34,775
    
    
    
    28,546Diluted
    
    
    44,415
    
    
    
    46,898
 Reconciliation of Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) to net
income (loss) in (000s):
 Three Months
    
    Three Months
    
    Nine Months
    
    Nine MonthsEnded
    
    Ended
    
    Ended
    
    EndedSeptember 30,
    
    September 30,
    
    September 30,
    
    September 30,2009
    
    2008
    
    2009
    
    2008EBITDA
    
    $
    1,496
    
    
    $
    230
    
    
    $
    3845
    
    
    $
    1,302Other income (expenses), net
    
    
    (164
    )
    
    
    (164
    )
    
    
    (542
    )
    
    
    (126
    )Income tax benefit (expense)
    
    
    143
    
    
    
    54
    
    
    
    (563
    )
    
    
    (430
    )Depreciation and
amortization
    
    
    (372
    )
    
    
    (348
    )
    
    
    (1,043
    )
    
    
    (462
    )Net income
    
    $
    1,103
    
    
    $
    (228
    )
    
    $
    1,697
    
    
    $
    284
 4




---



##### 



GLOBAL MED TECHNOLOGIES, INC. (OTC Bulletin Board: GLOB.OB)
 Selected Cash Flow Information (Unaudited)
Nine Months Ended September 30,
In (000s)
 2009
    
    2008Cash flows provided by (used in):Operations
    
    $
    3,872
    
    
    $
    1,114Investing activities
    
    
    (367
    )
    
    
    (9,879
    )Financing activities
    
    
    (1,552
    )
    
    
    8,652Effect of exchange rates on cash
    
    
    45
    
    
    
    (116
    )Net increase (decrease) in cash
    
    
    1,998
    
    
    
    (229
    )Cash, beginning of period
    
    
    4,472
    
    
    
    6,748Cash, end of period
    
    $
    6,470
    
    
    $
    6,519
 Selected Balance Sheet Information
In (000s)
 September 30,
    
    December 31,2009
    
    2008(Unaudited)Cash, cash equivalents and marketable securities
    
    $
    6,799
    
    
    $
    4,660Other current assets
    
    
    6,457
    
    
    
    9,566Current assets
    
    
    13,256
    
    
    
    14,226PP&E
    
    
    1,249
    
    
    
    1,385Intangible assets
    
    
    13,959
    
    
    
    14,081Other long-term assets
    
    
    88
    
    
    
    92Total assets
    
    $
    28,552
    
    
    $
    29,784Accounts payable, accrued expenses and other
current liabilities
    
    $
    7,078
    
    
    $
    6,759Deferred revenue
    
    
    4,761
    
    
    
    6,361Current portion of long-term debt
    
    
    2,370
    
    
    
    2,335Total current liabilities
    
    $
    14,209
    
    
    
    15,455Long-term debt
    
    
    5,976
    
    
    
    7,853Other long-term liabilities
    
    
    73
    
    
    
    1,065Total liabilities
    
    
    20,258
    
    
    
    24,373Total stockholders equity
    
    
    8,294
    
    
    
    5,411Total liabilities and stockholders equity
    
    $
    28,552
    
    
    $
    29,784
 5




---



##### 



About Global Med Technologies ® , Inc.
  Wyndgate Technologies ® eDonor ® Hemo-Net®, PeopleMed ® , Inc
 Inlog, SA
  This news release may include statements that constitute forward-looking statements, usually
containing the words believe, estimate, project, expects or similar expressions. These
statements are made pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that
could cause actual results to differ materially from the forward-looking statements. By making
these forward-looking statements, the Company undertakes no obligation to update these statements
for revisions or changes after the date of this news release.
 Company Contact:
    
    Investor Contact:Global Med Technologies, Inc.
    
    Attn: Investor RelationsMichael I. Ruxin, M.D.
    
    Jeffrey Benison(303) 238-2000
    
    (212) 334-8709Email: jeffrey@littlegems.us
 6